He is 62 years old and has been vaccinated 217 times against covid: what scientists discovered in his body

A 62-year-old man decided this get vaccinated 217 times against covid, despite doctors’ advice not to do so. Scientists investigated how your body reacted and the result surprised everyone.

According to the magazine The Lancet infectious diseases in its last issue, vaccines were purchased and administered privately for a period of 29 months.

The man born in Germany, whose identity has not been revealedhas become the subject of study in light of what the coronavirus pandemic has left behind and some reasonable fears.

How the man reacted to the 217 doses of the covid vaccine

“We learned about his case through newspaper articles. Then we contacted him and invited him to undergo various tests in Erlangen,” he explains. Kilian Schoberof the University of Erlangen-Nuremberg.

This is how experts from the microbiology department of the German university began to intervene blood and saliva samples.

“We were able to take blood samples ourselves when the man received another vaccine during the study at his insistence. In this way we determined exactly how the immune system reacts to the vaccine“added the former scientist.

Schober and his team were concerned about overstimulation of the immune system with repeated doses it could cause fatigue in the cells.

However, no evidence was found of this situation in humans e there were no signs that he had ever been infected with covid.

In any case, it is worth noting, experts have emphasized this They don’t support a person who gets vaccinated so many times as a strategy to improve immunity in the case of this pandemic that has hit the world.

Insufficient results

The results of the tests carried out on the German were insufficient to draw far-reaching conclusionslet alone formulate recommendations for the public, warn the EFE agency.

Thus, from the Study Center, they warn: “Current research indicates this a three-dose vaccinetogether with regular follow-up vaccinations for vulnerable groups, remains the preferred approach.”